Low tacrolimus exposure in combination with mycophenolate mofetil is safe and effective compared to standard tacrolimus exposure following liver transplant.

被引：0
|
作者：
Marotta, P
Nashan, B
Saliba, F
Durand, F
Bowles, M
Patch, D
Bernardos, A
Truman, M
Ives, J
Mamelok, R
机构：
[1] Univ Hosp, London, ON, Canada
[2] Dalhousie Univ, Halifax, NS, Canada
[3] Hop Paul Brousse, Villejuif, France
[4] Hop Beaujon, Clichy, France
[5] Univ London Kings Coll, London WC2R 2LS, England
[6] Royal Free Hosp, London NW3 2QG, England
[7] Virgen Del Rocio, Seville, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1240
引用
收藏
页码：472 / 472
页数：1
相关论文
共 50 条
  • [21] Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study
    Saliba, Faouzi
    Rostaing, Lionel
    Gugenheim, Jean
    Durand, Francois
    Radenne, Sylvie
    Leroy, Vincent
    Neau-Cransac, Martine
    Calmus, Yvon
    Salame, Ephrem
    Pageaux, Georges-Philippe
    Duvoux, Christophe
    Taguieva, Naila
    Sinnasse-Raymond, Gilles
    Sebagh, Mylene
    Samuel, Didier
    Marquet, Pierre
    TRANSPLANTATION, 2016, 100 (08) : 1705 - 1713
  • [22] Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation
    Mourad, M
    Malaise, J
    Eddour, DC
    De Meyer, M
    König, J
    Schepers, R
    Squifflet, JP
    Wallemacq, P
    CLINICAL CHEMISTRY, 2001, 47 (07) : 1241 - 1248
  • [23] Combination of Everolimus and Tacrolimus in Kidney Transplant Patients With Intolerance to Mycophenolate Mofetil/Mycophenolic Acid
    Balda, S.
    Inza, A.
    Odriozola, N.
    Zarraga, S.
    Garcia-Erauskin, G.
    Lampreabe, I.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2095 - 2098
  • [24] IMPACT OF TACROLIMUS EXPOSURE ON CANCER-RELATED MORTALITY FOLLOWING LIVER TRANSPLANT
    Cui, Jiawei
    Coe, Christopher L.
    Oje, Adesola Oluwagbemiga
    Spann, Ashley
    Fan, Lei
    Shingina, Alexandra
    Shrubsole, Martha
    Watt, Kymberly
    Baljevic, Muhamed
    Izzy, Manhal
    HEPATOLOGY, 2023, 78 : S320 - S320
  • [25] Relationship of Tacrolimus Exposure and Mycophenolate Mofetil Dose With Renal Function After Renal Transplantation
    Ekberg, Henrik
    van Gelder, Teun
    Kaplan, Bruce
    Bernasconi, Corrado
    TRANSPLANTATION, 2011, 92 (01) : 82 - 87
  • [26] Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients
    Figueras, J
    Bernardos, A
    Prieto, M
    Gómez, M
    Rimola, A
    de Urbina, JO
    Cuervas-Mons, V
    de la Mata, M
    Dominguez-Granados, R
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1511 - 1513
  • [27] A new model to determine Optimal Exposure to Tacrolimus and Mycophenolate Mofetil after renal transplantation
    Pankewycz, Oleh
    Onan, Engin
    Rucker, Dane
    Wang, Dongliang
    Gruessner, Angelika
    Gruessner, Rainer
    Laftavi, Mark R.
    CLINICAL TRANSPLANTATION, 2020, 34 (07)
  • [28] Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients
    Yeung, S
    Tsang, WK
    Tong, KL
    Wong, SH
    Lee, W
    Tang, HL
    Chan, HWH
    Chan, AYW
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2084 - 2086
  • [29] Everolimus/Low Tacrolimus Exposure versus Sodium Mycophenolate/ Standard Tacrolimus for the Elderly Kidney Transplant Recipient. A 4-y Follow -Up of the nEverOld Trial
    David-Neto, E.
    Agena, F.
    Paula, F. J.
    Galante, N. Z.
    David, D. S.
    Ramos, F.
    Triboni, A. K.
    Romano, P.
    Ebner, P. A.
    Coelho, V.
    Altona, M.
    Falci, R.
    Piovesan, A.
    Nahas, W. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 689 - 690
  • [30] Tacrolimus Exposure and Mycophenolate Pharmacokinetics and Pharmacodynamics Early After Liver Transplantation
    Saeves, Ingjerd
    Line, Pal-Dag
    Bremer, Sara
    Vethe, Nils T.
    Tveit, Ragnhild G.
    Meltevik, Tore J.
    Bergan, Stein
    THERAPEUTIC DRUG MONITORING, 2014, 36 (01) : 46 - 53
12345